Menu Close

Articles on Sovaldi

Displaying all articles

Sen. Chuck Grassley, R-Iowa, chair of the Senate Finance Committee, prepares for the Feb. 26, 2019 hearing with CEOs from several U.S. drug makers. Pablo Martinez Monsivais/AP Photo

A new way to pay for innovative drugs, provide universal access and not break the bank

As concern grows for the escalating prices of prescription drugs, a novel approach to lower the price of drugs to treat hepatitis C in Louisiana holds promise, a policy expert says.
The proposed Australian price for Sovaldi has not been disclosed, but in the United States a three-month course of treatment costs US$84,000. Stuart Hamilton/Flickr

What price a life? Hepatitis C drug out of reach for millions

It’s twice as common as type 1 diabetes. It kills more Australians than HIV. One in every 100 of us lives with hepatitis C, but the disease receives little attention. Worldwide, around 150 million people…

Top contributors